Preview

Osteoporosis and Bone Diseases

Advanced search

POSSIBILITIES OF USING DENOSUMAB IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM

About the Authors

I. V. Kryukova
Moscow Regional Clinical Research Institute named after M.F. Vladimirsky (MONIKI)
Russian Federation

Moscow



A. V. Dreval
Moscow Regional Clinical Research Institute named after M.F. Vladimirsky (MONIKI)
Russian Federation

Moscow



L. H. Tevosyan
Moscow Regional Clinical Research Institute named after M.F. Vladimirsky (MONIKI)
Russian Federation

Moscow



E. Yu. Polyakova
Moscow Regional Clinical Research Institute named after M.F. Vladimirsky (MONIKI)
Russian Federation

Moscow



I. A. Barsukov
Moscow Regional Clinical Research Institute named after M.F. Vladimirsky (MONIKI)
Russian Federation

Moscow



O. N. Zolotareva
Moscow Regional Clinical Research Institute named after M.F. Vladimirsky (MONIKI)
Russian Federation

Moscow



Review

For citations:


Kryukova I.V., Dreval A.V., Tevosyan L.H., Polyakova E.Yu., Barsukov I.A., Zolotareva O.N. POSSIBILITIES OF USING DENOSUMAB IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM. Osteoporosis and Bone Diseases. 2020;23(2):80-81. (In Russ.)

Views: 280


ISSN 2072-2680 (Print)
ISSN 2311-0716 (Online)